AAAAAA

   
Results: 1-16 |
Results: 16
The long-term response to levodopa in dopa-responsive dystonia
Authors: Hwang, WJ Calne, DB Tsui, JKC de la Fuente-Fernandez, R
Citation: Wj. Hwang et al., The long-term response to levodopa in dopa-responsive dystonia, PARKINS R D, 8(1), 2001, pp. 1-5
Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene)
Authors: Pal, PK Wszolek, ZK Kishore, A de la Fuente-Fernandez, R Sossi, V Uitti, RJ Dobko, T Stoessl, AJ
Citation: Pk. Pal et al., Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene), PARKINS R D, 7(2), 2001, pp. 81-88
An open letter to the Committee on the Nobel Prize in Medicine
Authors: Abbruzzese, G Agid, Y Albanese, A Alf, C Allen, R Amar, K de Andrade, LA Ang, LC Angelini, C Archer, RL Arunodaya, GR Baltzan, M Baral, K Barnett, H Bergamasco, B Berger, M Bernard, J Bharucha, NE Bhatia, K Blary, N Black, S Bodis-Wollner, I Boyson, SJ Bral-Kulaksizoglu, I Brooks, DJ Brown, JD Burke, RE Calne, DOC Calne, SM Cardoso, F Cardozo-Pelaez, F Chang, YJ Chen, CC Chen, RS Chen, R Chowdhury, A Christie, S Chu, CC Chu, NS Clarida, L Collette, EM Comella, C Conneally, PM Crossman, AR Csanda, E Dalmau, J Dalvi, A De Feijter, A Deecke, L Desai, H De Ybenes, J Dihenia, B Direnfeld, L Dodel, R Donat, J Doudet, D Duane, DD Duff, J Duvoisin, R Eggert, K Elble, RJ Elmer, LW Emre, M Fariello, R Fernendy, HH Findley, LJ Fink, S Freissmuth, M Friedman, JH de la Fuente-Fernandez, R Furtado, S Furukawa, Y Galvez-Jimenez, N Gauthier, S Gawel, MJ Gilman, S Gladstone, RM Goetz, CG Gomori, A Gopinathan, G Gordin, A Gorell, JM Greenamyre, JT Grimes, DA Gurvit, H Guttman, M Guzman, DA Hachinski, V Hanagasi, H Hardy, J Harik, SJ Hassan, MN Hattori, N Hauser, RA Hayashi, H Heller, GL Hobson, D Hochschorner, G Hortnagel, H Horowski, R Howse, DC Huang, CC Huk, II Hurtig, H Hutton, JT Jaffe, ME Jankovic, J Jardine, M Jog, M Johnson, B Kagamihara, Y Karagoz, N Kasper, S Kato, S Kebabian, JW Kertsz, A Khadilkar, SV Kirk, A Kish, S Kitaguchi, T Kofman, OS Koide, R Komori, T Kostyuk, PG Kumar, R Kuo, HC Kurlan, R Kurland, L Kurtuncu, M Lalkaka, JA Lambert, M Landau, W Lang, AE Lassmann, H Lee, CS Lees, AJ Lieberman, A Litvan, I Loeb, C Logan, WJ Lozano, AM Lu, CS Lucy, D Lynch, T Manyam, BV Maraganore, D Marshall, FT Martin, WRW Martin, WE Mathias, C Matsubera, S Mendis, T Menkes, JH Metz, LN Miyazaki, Y Mizuno, Y Mohr, E Moodley, LG Moore, R Morris, JL Muthane, U Nagaraja, D Nair, CPV Narabayashi, H Nomura, Y Norris, JW Obeso, JA O'Brien, C Oertel, W Ohtake, T Okiyama, R Ozdemir, C Pal, PK Panisset, M Paty, DW Paulson, GW Perlmutter, J Pfeiffer, RF Pifl, C Pincus, JH Poewe, W Quinn, N Rajput, AH Rajput, A Ransmayr, G Rascol, O Robinson, R Rocca, WA Roos, RAC Rosenfeld, MR Russell, D Ruth, TJ Ryu, SJ Sachdev, H Safoschnik, G Sahin, H Sanchez-Ramos, J Satishchandra, P Schapira, A",Scheltens,"Schmidley, JW Schnaberth, G Schneider, E Schneider, JS Schutz, W Seeberger, LC Segawa, M Sethi, KD Shah, A Shannon, K Shelton, P Shihabuddin, B Shimizu, T Shinotoh, H Siddique, T Siderowf, A Sieghart, W Simard, A Simmonds, DC Singhal, BS Sluga, E Snow, BJ Soukop, W Sperk, G Spieker, S Steele, JC Stewart, S Stoessl, AJ Subramony, SH Sundaram, M Sung, CY Surya, N Sweet, RD Tabbal, SD Takahashi, H Taniguchi, M Tarsy, D Teravainen, H Tetrud, JW Tolosa, E Tourtellotte, WW Troupin, AS Tsui, JKC Tuite, P Uc, EY Ueki, Y Uitti, R Uyu, C van Hilten, JJ Veerendrakumar, M Veloso, F Viallet, F Voll, C Vrooman, M Wang, X Ward, I Ward, A Waters, C Weng, YH Wenning, GK Williams, BJ Wilson, TW Wolters, EC Wooten, FG Wszolek, Z Yahr, MD Yanagisawa, N Yokochi, F Young, RR Yu, CM Zifko, U
Citation: G. Abbruzzese et al., An open letter to the Committee on the Nobel Prize in Medicine, PARKINS R D, 7(2), 2001, pp. 149-155
Pharmacodynamic modeling of oral levodopa in Parkinson's disease - Reply
Authors: de la Fuente-Fernandez, R Stoessl, AJ
Citation: R. De La Fuente-fernandez et Aj. Stoessl, Pharmacodynamic modeling of oral levodopa in Parkinson's disease - Reply, ANN NEUROL, 50(5), 2001, pp. 688-688
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
Authors: de la Fuente-Fernandez, R Lu, JQ Sossi, V Jivan, S Schulzer, M Holden, JE Lee, CS Ruth, TJ Calne, DB Stoessl, AJ
Citation: R. De La Fuente-fernandez et al., Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover, ANN NEUROL, 49(3), 2001, pp. 298-303
Apomorphine-induced changes in synaptic dopamine levels: Positron emissiontomography evidence for presynaptic inhibition
Authors: de la Fuente-Fernandez, R Lim, AS Sossi, V Holden, JE Calne, DB Ruth, TJ Stoessl, AJ
Citation: R. De La Fuente-fernandez et al., Apomorphine-induced changes in synaptic dopamine levels: Positron emissiontomography evidence for presynaptic inhibition, J CEREBR B, 21(10), 2001, pp. 1151-1159
The use and usefulness of placebo controls - Response
Authors: de la Fuente-Fernandez, R Stoessl, AJ
Citation: R. De La Fuente-fernandez et Aj. Stoessl, The use and usefulness of placebo controls - Response, SCIENCE, 294(5543), 2001, pp. 785-785
Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease
Authors: de la Fuente-Fernandez, R Ruth, TJ Sossi, V Schulzer, M Calne, DB Stoessl, AJ
Citation: R. De La Fuente-fernandez et al., Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease, SCIENCE, 293(5532), 2001, pp. 1164-1166
Familial aggregation of Parkinson's disease.
Authors: de la Fuente-Fernandez, R Calne, DB
Citation: R. De La Fuente-fernandez et Db. Calne, Familial aggregation of Parkinson's disease., N ENG J MED, 344(15), 2001, pp. 1168-1168
Maternal effect on Parkinson's disease
Authors: de la Fuente-Fernandez, R
Citation: R. De La Fuente-fernandez, Maternal effect on Parkinson's disease, ANN NEUROL, 48(5), 2000, pp. 782-787
In vivo positron emission tomographic evidence for compensatory changes inpresynaptic dopaminergic nerve terminals in Parkinson's disease
Authors: Lee, CS Samii, A Sossi, V Ruth, TJ Schulzer, M Holden, JE Wudel, J Pal, PK de la Fuente-Fernandez, R Calne, DB Stoessl, AJ
Citation: Cs. Lee et al., In vivo positron emission tomographic evidence for compensatory changes inpresynaptic dopaminergic nerve terminals in Parkinson's disease, ANN NEUROL, 47(4), 2000, pp. 493-503
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
Authors: de la Fuente-Fernandez, R Pal, PK Vingerhoets, FJG Kishore, A Schulzer, M Mak, EK Ruth, TJ Snow, BJ Calne, DB Stoessl, AJ
Citation: R. De La Fuente-fernandez et al., Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations, J NEURAL TR, 107(1), 2000, pp. 49-57
Nigrostriatal dopamine system and motor lateralization
Authors: de la Fuente-Fernandez, R Kishore, A Calne, DB Ruth, TJ Stoessl, AJ
Citation: R. De La Fuente-fernandez et al., Nigrostriatal dopamine system and motor lateralization, BEH BRA RES, 112(1-2), 2000, pp. 63-68
Guillain-Barre syndrome as first manifestation of typhoid fever
Authors: Aldrey, JM Fernandez-Rial, A Lopez-Gonzalez, FJ Doval, JC de la Fuente-Fernandez, R
Citation: Jm. Aldrey et al., Guillain-Barre syndrome as first manifestation of typhoid fever, CLIN INF D, 28(5), 1999, pp. 1171-1172
Drug-induced motor complications in dopa-responsive dystonia: Implicationsfor the pathogenesis of dyskinesias and motor fluctuations
Authors: de la Fuente-Fernandez, R
Citation: R. De La Fuente-fernandez, Drug-induced motor complications in dopa-responsive dystonia: Implicationsfor the pathogenesis of dyskinesias and motor fluctuations, CLIN NEUROP, 22(4), 1999, pp. 216-219
The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease
Authors: de la Fuente-Fernandez, R Nunez, MA Lopez, E
Citation: R. De La Fuente-fernandez et al., The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease, CLIN NEUROP, 22(4), 1999, pp. 226-230
Risultati: 1-16 |